Elekta partners with MSD to enhance kidney cancer care using digital solutionsSTOCKHOLM – Elekta (EKTA-B.ST) today announced a partnership with MSD (Merck & Co., Inc., Rahway, N.J., USA) to develop digital patient monitoring for people with advanced renal cell carcinoma (RCC), using Elekta’s Kaiku He.